Last updated on March 2019

Safety Tolerability Pharmacokinetics and Efficacy of LMB763 in Patients With NASH


Brief description of study

The purpose of the present study is to assess the effects of LMB763 with respect to safety, tolerability, and on markers of liver inflammation in patients with NASH

Clinical Study Identifier: NCT02913105

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Miami Springs, FL United States

Novartis Pharmaceuticals

Novartis Investigative Site
Orlando, FL United States

Novartis Pharmaceuticals

Novartis Investigative Site
Baton Rouge, LA United States

Novartis Pharmaceuticals

Novartis Investigative Site
Nedlands, Australia

Novartis Pharmaceuticals

Novartis Investigative Site
Tbilisi, Georgia

Novartis Pharmaceuticals

Novartis Investigative Site
San Juan, Puerto Rico

Novartis Pharmaceuticals

Novartis Investigative Site
Bern, Switzerland

Novartis Pharmaceuticals

Novartis Investigative Site
Lugano, Switzerland

Novartis Pharmaceuticals

Novartis Investigative Site
Headington, United Kingdom

Novartis Pharmaceuticals

Novartis Investigative Site
Glasgow, United Kingdom

Novartis Pharmaceuticals

Novartis Investigative Site
Geneve 14, Switzerland

Novartis Pharmaceuticals

Novartis Investigative Site
Boston, MA United States

Novartis Pharmaceuticals

Novartis Investigative Site
High Point, NC United States

Novartis Pharmaceuticals

Novartis Investigative Site
Houston, TX United States

Novartis Pharmaceuticals

Novartis Investigative Site
Papatoetoe, New Zealand

Novartis Pharmaceuticals

Novartis Investigative Site
Llantrisant, United Kingdom

Novartis Pharmaceuticals

Novartis Investigative Site
London, United Kingdom

Novartis Pharmaceuticals

Novartis Investigative Site
St Gallen, Switzerland

Novartis Pharmaceuticals

Novartis Investigative Site
Culver City, CA United States

Novartis Pharmaceuticals

Novartis Investigative Site
Cypress, CA United States

Novartis Pharmaceuticals

Novartis Investigative Site
Gainesville, FL United States

Novartis Pharmaceuticals

Novartis Investigative Site
Honolulu, HI United States

Novartis Pharmaceuticals

Novartis Investigative Site
Nashville, TN United States

Novartis Pharmaceuticals

Novartis Investigative Site
Arlington, TX United States

Novartis Pharmaceuticals

Novartis Investigative Site
Newport News, VA United States

Novartis Pharmaceuticals

Novartis Investigative Site
New Lambton, Australia

Professor Shennak

Novartis Investigative Site
Amman, Jordan

Novartis Pharmaceuticals

Novartis Investigative Site
Auckland, New Zealand

Novartis Pharmaceuticals

Novartis Investigative Site
Christchurch, New Zealand

Novartis Pharmaceuticals

Novartis Investigative Site
Tauranga, New Zealand

Dean Quinn

Novartis Investigative Site
Wellington, New Zealand

Novartis Pharmaceuticals

Novartis Investigative Site
Plymouth, United Kingdom

Richard Aspinall, MD

Novartis Investigative Site
Portsmouth, United Kingdom

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.